KemPharm Inc.

KemPharm Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$45.63 M
Shares Outstanding
28.52 M
Public Float
23.39 M


1180 Celebration Boulevard
Celebration Florida 34747
United States
Employees -
Updated 07/08/2019
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M.


View All

Travis C. Mickle
Chairman, President & Chief Executive Officer
David S. Tierney
Independent Director